|
Product Details:
Payment & Shipping Terms:
|
| CAS: | 872365-14-5 | Product Name: | Fevipiprant |
|---|---|---|---|
| Type: | Anti-hair Loss Powder | Appearance: | White Powder |
| Usage: | Anti-hair Loss Powder | Alias: | Fevipiprant |
| Assay: | 99% | Key Words: | Fevipiprant |
| High Light: | anti estrogen steroids,hair growing powder |
||
Anti-hair Loss Powder API Fevipiprant(NVP-QAW039) Fevipiprant CAS 872365-14-5
Quick Details
| Name | Formestane |
| CAS No. | 566-48-3 |
| EINECS | N/A |
| MF | C19H26O3 |
| MW | 302.41 |
| MP | 199-202°C |
| Storage temp. | 2-8°C |
| Purity | 99% min |
| Usage | An antitumor drug. An aromatase inhibitor |
| Appearance | Needles |
Formestane also is known as lentaron,is an anti-cancer drug, it is primarily used for the treatment of postmenopausal women with advanced breast cancer, it is also effective in prostate cancer
Introduction:
1) Product Name:Supply Anti-hair Fevipiprant powder CAS 872365-14-5
2) Purity: ≥99%
3) Appearance: White fine powder
4) Introduction:
Fevipiprant (INN; code name QAW039) is a drug being developed by Novartis which acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2 or CRTh2).[1][2][3
As of 2016, it is in Phase III[4] clinical trials for the treatment of asthma.[5]
Setipiprant (INN) (developmental code names ACT-129,968, KYTH-105) is a drug originally developed by Actelionwhich acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2).[1] It was initially researched as a treatment for allergies and inflammatory disorders, particularly asthma, but despite being well tolerated in clinical trials and showing reasonable efficacy against allergen-induced airway responses in asthmatic patients,[2][3] it failed to show sufficient advantages over existing drugs and was discontinued from further development in this application.
Anti-hair Loss Powder API Fevipiprant(NVP-QAW039) Fevipiprant CAS 872365-14-5
Contact Person: Mr. Bruce Lee
Tel: +8618874586545
Fax: 86-27-8321-4688
